Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.
OTC
Unprofitable
Unprofitable
10M
Biotechnology
Next Earning date - 06 Aug 2025
10M
Biotechnology
Next Earning date - 06 Aug 2025
Relative Strenght
84Volume Buzz
-72%Earning Acce
YesDist 52w H.
82%